Episode 33 - Mark Mallon, CEO George Medicines

Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. We have Mark Mallon, CEO of George Medicines.

Mark is a global leader in the pharmaceutical industry with over 25 years of experience. His career includes 24 years at AstraZeneca, where he held several key executive positions, leading operations across the globe.

More recently, Mark has served as the CEO of NeoGenomics Laboratories and Ironwood Pharmaceuticals, driving transformation and growth in both roles. Now at George Medicines, Mark leads the development of innovative, combination therapies designed to optimize the treatment of cardiometabolic diseases.

In this episode, we’ll explore Mark’s journey to George Medicines, the company’s innovative approach to tackling cardiometabolic diseases, and the importance of addressing global health inequities.

Welcome to the show, Mark! Enjoy and stay tuned.